📰 Michael Pulsipher News
Michael Pulsipher News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Michael Pulsipher. Real-time updates on events, politics, business and more.
April 18, 2024
WASHINGTON, April 18, 2024 (GLOBE NEWSWIRE) -- In a first-of-its-kind clinical trial, researchers found that intravenous therapies made from vir...
August 8, 2023
CURE provides access to the cancer news, latest oncology research & expert insights that serve as a guide to every stage of the cancer experience.
December 1, 2021
Bottom Line: In pediatric and young adult patients with acute lymphoblastic leukemia (ALL) treated with tisagenlecleucel (Kymriah), DNA
December 1, 2021
In pediatric and young adult patients with acute lymphoblastic leukemia (ALL) treated with tisagenlecleucel (Kymriah), DNA sequencing-based detection of residual disease between three and 12 months accurately identified all patients who would eventually relapse, while other methods were less predictive.
December 1, 2021
Nearly all patients with detectable disease relapsed or progressed to transplant, other therapies
December 1, 2021
In pediatric and young adult patients with acute lymphoblastic leukemia (ALL) treated with tisagenlecleucel (Kymriah), DNA sequencing-based detection accurately identified all patients who would eventually relapse, while other methods were less predictive, according to a study published in Blood Cancer Discovery, a journal of the American Association for Cancer Research.